Abstract: A liquid surfactant composition can include a C9-C20 alkylbenzene sulfonate, a nonionic surfactant, and an anionic surfactant. The anionic surfactant can include a first alcohol ether sulfate (AES) surfactant and a second AES surfactant. The first AES surfactant can have a molecular formula of R1—O—(CH2—CH2—O)m—SO3M, wherein R1 represents a C10-C20 alkyl group, m represents a number from 6 to 8, and M represents a monovalent cation. The second AES surfactant can have a molecular formula of R2—O—(CH2—CH2—O)n—SO3M?, wherein R2 represents a C10-C20 alkyl group, n is 2 or 3, and M? represents a monovalent cation. The first AES surfactant and the second AES surfactant can be present in the liquid surfactant composition at a weight ratio to provide the liquid surfactant composition with a fresh viscosity from about 350 centipoise (cPS) to about 550 cps.

Abstract: A liquid surfactant composition can include a C9-C20 alkylbenzene sulfonate, a first alcohol ether sulfate (AES), and a nonionic surfactant. The first AES surfactant can have a molecular formula of R1—O—(CH2—CH2—O)m—SO3M, wherein R1 represents a C10-C20 alkyl group, m represents a number from 6 to 8, and M represents a monovalent cation. The first AES surfactant can be a modified oxo-alcohol-based surfactant.

Abstract: A liquid surfactant composition can include a C9-C20 alkylbenzene sulfonate, a first alcohol ether sulfate (AES), and a nonionic surfactant. The first AES surfactant can have a molecular formula of R1—O—(CH2—CH2—O)m—SO3M, wherein R1 represents a C10-C20 alkyl group, m represents a number from 6 to 8, and M represents a monovalent cation. The first AES surfactant can be a modified oxo-alcohol-based surfactant.

Abstract: A liquid surfactant composition can include a C9-C20 alkylbenzene sulfonate, a nonionic surfactant, and an anionic surfactant. The anionic surfactant can include a first alcohol ether sulfate (AES) surfactant and a second AES surfactant. The first AES surfactant can have a molecular formula of R1—O—(CH2—CH2—O)m—SO3M, wherein R1 represents a C10-C20 alkyl group, m represents a number from 6 to 8, and M represents a monovalent cation. The second AES surfactant can have a molecular formula of R2—O—(CH2—CH2—O)n—SO3M?, wherein R2 represents a C10-C20 alkyl group, n is 2 or 3, and M? represents a monovalent cation. The first AES surfactant and the second AES surfactant can be present in the liquid surfactant composition at a weight ratio to provide the liquid surfactant composition with a fresh viscosity from about 350 centipoise (cPS) to about 550 cps.

Abstract: The invention includes a medical hydrogel made from polymerized polysaccharide macromers. The macromers are preferably polysaccharides decorated with polymerizable groups, for example, methacrylates. The macromers may also be made into polymers of at least two macromers polymerized together. These polymers are preferably multi-armed or high-molecular weight and used for medical uses, for example, making coatings on medical devices. Macromers of N-vinylpyrrolidone are also disclosed herein.

Abstract: The invention includes a medical hydrogel made from polymerized polysaccharide macromers. The macromers are preferably polysaccharides decorated with polymerizable groups, for example, methacrylates. The macromers may also be made into polymers of at least two macromers polymerized together. These polymers are preferably multi-armed or high-molecular weight and used for medical uses, for example, making coatings on medical devices. Macromers of N-vinylpyrrolidone are also disclosed herein.

Abstract: The invention includes a medical hydrogel made from polymerized polysaccharide macromers. The macromers are preferably polysaccharides decorated with polymerizable groups, for example, methacrylates. The macromers may also be made into polymers of at least two macromers polymerized together. These polymers are preferably multi-armed or high-molecular weight and used for medical uses, for example, making coatings on medical devices. Macromers of N-vinylpyrrolidone are also disclosed herein.

Abstract: Materials and methods for reacting polysaccharides are set forth. Examples include reacting polysaccharides with a surface, and reacting polysaccharides with other polysaccharides or polymers to form a polysaccharide polymer. Layers of polysaccharides and/or polysaccharide polymers may be formed on surfaces, for example, medical device surfaces that contact bodily fluids.

Abstract: The invention includes a medical hydrogel made from polymerized polysaccharide macromers. The macromers are preferably polysaccharides decorated with polymerizable groups, for example, methacrylates. The macromers may also be made into polymers of at least two macromers polymerized together. These polymers are preferably multi-armed or high-molecular weight and used for medical uses, for example, making coatings on medical devices. Macromers of N-vinylpyrrolidone are also disclosed herein.

Abstract: A warp knitted vascular patch material, made in specific widths, the selvedges of the material are specially finished on the knitting machine without the introduction of additional threads to give a strong edge which will not fray and give firm support for the sutures. The specially knitted edges enables small neat sutures to be made without the risk of pulling out. This prevents all the problems of fraying edges and bulky seams found when unsized material is cut to the required width. This patch material is designed specifically for arterial closure following a carotid endorectomy.

Abstract: The present invention provides vascular prostheses free of any substance that counteracts an anticoagulant comprising a base material, the base material having inner and outer surfaces, wherein the outer surface has a layer of a material capable of reducing the porosity of said prosthesis to blood or body fluid and a coating of compounded heparin bound thereon, and the inner surface has a coating of compounded heparin bound thereon, the compounded heparin comprising heparin and a cationic surfactant. The present invention also provides a method for forming a vascular prosthesis. The vascular prostheses of the present invention exhibit low porosity at the time of implantation of the prosthesis thereby obviating the need for pre-clotting the prosthesis to avoid leakage or hemorrhaging of blood through the prosthesis.

Abstract: A high solids slurry of surfactant, inorganic builders and filler salts, which may be spray dried to produce a granular laundry detergent, is prepared by contacting mixed organic and inorganic acids, such as produced in the first stage of the oleum sulfonation of detergent alkylates, with a dry alkali metal carbonate and then with water while subjecting the ingredients and reaction mixture to a controlled mulling/smearing action.

Abstract: The invention relates generally to products useful for home laundering, and more particularly to adjustable strength bleaching compositions, highly advantageous packaging of such compositions, and a method of bleaching involving the combination of the two. More specifically the invention relates to a home laundering composition containing a fabric-safe peroxygen bleach and an accompanying bleach activator system providing a convenient and effective means of achieving stronger bleaching action whenever desirable.

Abstract: One may enhance the soil release properties of textile fabrics, particularly polyester containing fabrics, by laundering same with a stable aqueous detergent composition having enhanced soil release properties and consisting essentially of:(a) 0.2 to 20.